Epilepsy and Pregnancy: What You Need to Know (2026)

By Michael Wright · May 20, 2025

Your Dream of Parenthood Is Possible — And Safer Than Ever Before

Yes, can people with epilepsy have kids — and the overwhelming answer from modern neurology and maternal-fetal medicine is a confident, well-supported "yes." In fact, over 90% of pregnancies in people with epilepsy result in healthy babies when managed proactively with a specialized care team. Yet many still delay or avoid parenthood due to outdated fears, misinformation, or lack of accessible, coordinated guidance. This isn’t just about biology — it’s about empowerment, informed choice, and reclaiming agency in one of life’s most profound transitions. With today’s advances in anti-seizure medications (ASMs), genetic counseling, prenatal monitoring, and multidisciplinary care, having epilepsy doesn’t mean sacrificing your vision of family. It means planning differently — more intentionally, more collaboratively, and with greater support than ever before.

Understanding Fertility & Epilepsy: What the Data Really Shows

Fertility rates among people with epilepsy are generally comparable to the general population — but nuances matter. A landmark 2022 study published in Neurology followed 1,247 adults with epilepsy over 5 years and found that 86% conceived within 12 months of trying — only 4% lower than national averages. However, certain factors can influence conception timelines: hormonal fluctuations tied to some ASMs (like valproate, which may affect ovulation), polycystic ovary syndrome (PCOS) prevalence (2–3× higher in women with epilepsy), and psychosocial barriers like anxiety or depression that impact sexual health and intimacy.

Importantly, fertility isn’t just a ‘woman’s issue’ — sperm quality can also be affected. Research from the Cleveland Clinic shows men taking older-generation ASMs (e.g., phenytoin, carbamazepine) may experience reduced sperm motility and increased DNA fragmentation. But newer agents like levetiracetam and lamotrigine show no clinically significant impact on semen parameters. That’s why preconception evaluation should always include both partners, not just the person with epilepsy.

Dr. Sarah Lin, a board-certified epileptologist and co-director of the Women’s Epilepsy Program at Massachusetts General Hospital, emphasizes: “Fertility challenges are often treatable — and rarely insurmountable. What we see far more frequently is preventable delay caused by patients waiting until they’re ‘seizure-free for 2 years’ before seeking help. That’s not evidence-based. We now recommend engaging a neurologist and OB-GYN before stopping contraception — ideally 3–6 months in advance.”

Your Preconception Plan: 5 Non-Negotiable Steps

Preconception care is where outcomes are won or lost — especially for people with epilepsy. Skipping this phase increases risk of unplanned pregnancy on suboptimal ASM regimens, missed folate supplementation, and delayed genetic counseling. Here’s your actionable roadmap:

ASM Review & Optimization: Work with your neurologist to assess if your current medication is pregnancy-compatible. Avoid valproate if possible — it carries the highest risk of major congenital malformations (6–10%) and neurodevelopmental delays (e.g., lower IQ, autism spectrum traits). Prioritize lamotrigine, levetiracetam, or oxcarbazepine, all with strong safety profiles and extensive pregnancy registry data.
Folic Acid Protocol: Start high-dose folic acid (4–5 mg/day) at least 3 months before conception. Standard prenatal vitamins (0.4–0.8 mg) aren’t enough — studies show this dose reduces neural tube defect risk by up to 70% in people with epilepsy. Note: Take it separately from iron or calcium supplements, as they inhibit absorption.
Seizure History Documentation: Compile a detailed log: seizure type(s), frequency, triggers, EEG reports, MRI findings, and response to past treatments. Bring this to every appointment — it informs ASM adjustments and helps your OB identify red flags early.
Genetic Counseling Consultation: While most epilepsy is not inherited, ~30% of cases have a genetic component. A certified genetic counselor can interpret your specific diagnosis (e.g., SCN1A-related Dravet syndrome vs. self-limited focal epilepsy) and quantify recurrence risk — often much lower than assumed (typically 2–5%, not 50%).
Multidisciplinary Team Alignment: Confirm your OB-GYN has experience managing high-risk pregnancies — or refer to a Maternal-Fetal Medicine (MFM) specialist. Also involve your primary care provider for baseline labs (thyroid, vitamin D, liver/kidney function) and mental health support if needed.

Pregnancy, Seizures & Medication: Navigating the Real-World Shifts

Pregnancy changes everything — including how your body processes ASMs. Hormonal surges, expanded blood volume, and altered liver metabolism can cause drug levels to drop by 30–50% in the 2nd and 3rd trimesters. That’s why therapeutic drug monitoring (TDM) isn’t optional — it’s essential. Most experts recommend checking serum ASM levels every 4 weeks during pregnancy and adjusting doses accordingly.

But numbers alone don’t tell the full story. Consider Maya, 29, diagnosed with juvenile myoclonic epilepsy at 16. On lamotrigine 200 mg/day pre-pregnancy, her levels dropped to 2.1 mcg/mL (target: 5–12) by week 24 — and she experienced two brief myoclonic jerks. Her neurologist increased her dose to 300 mg/day split BID, and levels stabilized at 6.8 mcg/mL. She delivered a healthy daughter at 39 weeks with zero seizures during labor or postpartum.

The biggest misconception? That stopping ASMs prevents fetal harm. In reality, uncontrolled seizures pose far greater danger: generalized tonic-clonic seizures carry up to 10× higher risk of miscarriage, placental abruption, fetal hypoxia, and maternal injury. According to the International League Against Epilepsy (ILAE), maintaining seizure control is the single most important factor for positive outcomes — even if it requires continuing medication.

Delivery and postpartum require special attention too. Epidurals are safe and encouraged — they reduce stress-induced seizures. Vaginal delivery is preferred unless obstetric indications dictate C-section. Postpartum, ASM levels rebound rapidly; many people need dose reductions within days to avoid drowsiness or toxicity. And crucially: breastfeeding is strongly recommended. All first-line ASMs transfer into breast milk at low, clinically insignificant levels — and benefits (immune protection, bonding, reduced SIDS risk) vastly outweigh theoretical concerns. The American Academy of Pediatrics classifies lamotrigine and levetiracetam as “usually compatible with breastfeeding.”

Child Development, Genetics & Long-Term Family Health

Parents often worry: “Will my child inherit epilepsy?” The answer depends entirely on your specific etiology. For genetically complex or unknown causes (the majority), population-level risk remains low — around 2–5%. But for monogenic forms like SCN1A, KCNQ2, or DEPDC5 mutations, recurrence risk can range from 25–50% depending on inheritance pattern. That’s why genetic testing — increasingly accessible via whole-exome sequencing — is transformative. It clarifies risk, guides prenatal testing options (CVS or amniocentesis), and informs early developmental surveillance.

What about your child’s long-term health? Reassuringly, children born to parents with epilepsy do not have higher rates of intellectual disability, autism, or learning disorders — unless there’s an underlying genetic syndrome affecting both parent and child. A 2023 longitudinal study in JAMA Neurology tracked 412 children of parents with epilepsy for 10 years and found academic performance, social-emotional development, and physical health metrics were statistically indistinguishable from matched controls.

Still, proactive support matters. Early intervention services (speech, OT, PT) are available free through state programs if developmental delays emerge — and pediatricians trained in neurodevelopment can spot subtle signs earlier. As Dr. Lena Patel, pediatric neurologist and co-author of the AAP’s Epilepsy Care Guidelines, notes: “We don’t screen every child for epilepsy — but we do encourage routine developmental monitoring and open conversations about family history. Knowledge removes stigma and empowers families to advocate.”

Phase	Timeline	Key Actions	Who to Involve	Why It Matters
Preconception	3–6 months before trying	ASM optimization, 4–5 mg folic acid, genetic counseling, baseline labs, MFM referral	Neurologist, OB-GYN, genetic counselor, PCP	Reduces congenital anomaly risk by up to 70%; prevents unplanned pregnancy on high-risk meds
First Trimester	Weeks 1–13	Monthly ASM level checks, early ultrasound (nuchal translucency), continue high-dose folate	OB-GYN, neurologist, MFM specialist	Identifies structural anomalies early; ensures ASM dosing keeps pace with rising metabolism
Second/Third Trimester	Weeks 14–40	ASM level checks every 4 weeks, fetal growth scans, seizure action plan review, birth plan discussion	OB-GYN, MFM, neurologist, certified nurse-midwife (if applicable)	Prevents breakthrough seizures; monitors for fetal growth restriction linked to ASM effects
Postpartum	0–12 weeks after delivery	ASM level recheck within 72 hours, dose adjustment if needed, breastfeeding support, mental health screening	Neurologist, lactation consultant, OB-GYN, therapist	Prevents postpartum seizures and ASM toxicity; addresses perinatal mood disorders (affecting 25% of new parents with epilepsy)

Frequently Asked Questions

Can epilepsy medications cause birth defects?

Some older anti-seizure medications — particularly valproate — are associated with higher risks of major congenital malformations (6–10%) and neurodevelopmental delays. However, newer agents like lamotrigine and levetiracetam have robust safety data: large pregnancy registries (EURAP, North American AED Registry) show malformation rates of 2.1–2.9%, nearly identical to the general population (2–3%). The key is working with your neurologist before conception to optimize your regimen — not avoiding medication altogether.

Will my seizures get worse during pregnancy?

Seizure frequency changes vary widely: ~25% of people see improvement, ~50% remain stable, and ~25% experience increased frequency — usually due to falling ASM levels, sleep deprivation, or stress. Crucially, most increases are manageable with dose adjustments guided by therapeutic drug monitoring. Uncontrolled seizures pose far greater risks to both parent and baby than carefully managed medication.

Is it safe to breastfeed while taking epilepsy medication?

Yes — and strongly encouraged. All first-line ASMs transfer into breast milk at very low concentrations (typically <10% of maternal plasma levels). Lamotrigine and levetiracetam are classified as “compatible” by the American Academy of Pediatrics. Studies tracking hundreds of breastfed infants show no adverse effects on growth, development, or sedation. If you’re on multiple ASMs or newer agents, consult a lactation specialist familiar with epilepsy care.

Do I need a C-section if I have epilepsy?

No — epilepsy alone is not an indication for cesarean delivery. Vaginal birth is safe and preferred for most people with epilepsy. C-sections are only recommended for standard obstetric reasons (e.g., fetal distress, failure to progress, breech presentation). Epidurals are safe and often beneficial, as pain control reduces seizure triggers. Your birth plan should include a clear seizure action plan for labor staff — but it doesn’t override standard delivery protocols.

What if I have a seizure during labor or delivery?

While rare (<1% of deliveries), generalized tonic-clonic seizures during labor require immediate intervention: protect airway, administer IV benzodiazepine (e.g., lorazepam), and monitor fetal heart rate. Most hospitals have protocols for this. Importantly, having a seizure during labor does not automatically necessitate C-section — vaginal delivery can proceed safely once the seizure resolves and fetal status is reassuring. Your care team should practice this scenario in advance.

Common Myths About Epilepsy and Parenthood

Myth #1: “If you have epilepsy, your child will definitely inherit it.” — False. Most epilepsy is not directly inherited. Even in genetic forms, recurrence risk is often 2–5%, not 50%. Genetic counseling provides personalized, evidence-based risk assessment — not guesswork.
Myth #2: “Stopping your seizure medication before pregnancy is safer for the baby.” — Dangerous. Uncontrolled seizures increase miscarriage, preterm birth, and fetal injury risk far more than appropriately dosed, pregnancy-compatible ASMs. Preconception planning — not abrupt discontinuation — is the gold standard.

Take the Next Step — With Confidence and Support

You’ve just read what thousands of parents with epilepsy wish they’d known earlier: that your diagnosis doesn’t define your reproductive future — it informs it. With strategic preconception planning, a collaborative care team, and evidence-based choices, you can build the family you envision, safely and joyfully. Don’t wait for “perfect seizure control” to begin this journey. Start today: schedule your neurology visit, request a referral to Maternal-Fetal Medicine, and download our free Preconception Checklist for Epilepsy (includes ASM compatibility charts, folate tracker, and conversation starters for your care team). Parenthood isn’t about eliminating risk — it’s about navigating it wisely, supported by science and compassion.